Acute megakaryoblastic leukemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 55: Line 55:


==External link==
==External link==
* http://www.meds.com/leukemia/flow/flow with flow cytometry in AML Atlas]
* [http://www.med-ed.virginia.edu/courses/path/innes/wcd/myeloid1.cfm Histology at University of Virginia]
* [http://www.med-ed.virginia.edu/courses/path/innes/wcd/myeloid1.cfm Histology at University of Virginia]
* [http://pathy.med.nagoya-u.ac.jp/atlas/doc/node49.html#SECTION00418000000000000000 Images at Nagoya University]
* [http://pathy.med.nagoya-u.ac.jp/atlas/doc/node49.html#SECTION00418000000000000000 Images at Nagoya University]

Revision as of 13:44, 21 September 2012

Acute megakaryoblastic leukemia
ICD-O: Template:ICDO
MeSH D007947

WikiDoc Resources for Acute megakaryoblastic leukemia

Articles

Most recent articles on Acute megakaryoblastic leukemia

Most cited articles on Acute megakaryoblastic leukemia

Review articles on Acute megakaryoblastic leukemia

Articles on Acute megakaryoblastic leukemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Acute megakaryoblastic leukemia

Images of Acute megakaryoblastic leukemia

Photos of Acute megakaryoblastic leukemia

Podcasts & MP3s on Acute megakaryoblastic leukemia

Videos on Acute megakaryoblastic leukemia

Evidence Based Medicine

Cochrane Collaboration on Acute megakaryoblastic leukemia

Bandolier on Acute megakaryoblastic leukemia

TRIP on Acute megakaryoblastic leukemia

Clinical Trials

Ongoing Trials on Acute megakaryoblastic leukemia at Clinical Trials.gov

Trial results on Acute megakaryoblastic leukemia

Clinical Trials on Acute megakaryoblastic leukemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Acute megakaryoblastic leukemia

NICE Guidance on Acute megakaryoblastic leukemia

NHS PRODIGY Guidance

FDA on Acute megakaryoblastic leukemia

CDC on Acute megakaryoblastic leukemia

Books

Books on Acute megakaryoblastic leukemia

News

Acute megakaryoblastic leukemia in the news

Be alerted to news on Acute megakaryoblastic leukemia

News trends on Acute megakaryoblastic leukemia

Commentary

Blogs on Acute megakaryoblastic leukemia

Definitions

Definitions of Acute megakaryoblastic leukemia

Patient Resources / Community

Patient resources on Acute megakaryoblastic leukemia

Discussion groups on Acute megakaryoblastic leukemia

Patient Handouts on Acute megakaryoblastic leukemia

Directions to Hospitals Treating Acute megakaryoblastic leukemia

Risk calculators and risk factors for Acute megakaryoblastic leukemia

Healthcare Provider Resources

Symptoms of Acute megakaryoblastic leukemia

Causes & Risk Factors for Acute megakaryoblastic leukemia

Diagnostic studies for Acute megakaryoblastic leukemia

Treatment of Acute megakaryoblastic leukemia

Continuing Medical Education (CME)

CME Programs on Acute megakaryoblastic leukemia

International

Acute megakaryoblastic leukemia en Espanol

Acute megakaryoblastic leukemia en Francais

Business

Acute megakaryoblastic leukemia in the Marketplace

Patents on Acute megakaryoblastic leukemia

Experimental / Informatics

List of terms related to Acute megakaryoblastic leukemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Acute megakaryoblastic leukemia (AMKL) is a form of leukemia where a majority of the blasts are megakaryoblastic.[1]

It is classified under M7 in the French-American-British classification.[2]

In the first three years of life megakaryoblastic leukemia is the most common type of leukemia in patients with Downs syndrome.[3]

Pathophysiology

It is associated with GATA1, and risks are increased in individuals with Down syndrome.[4] However, not all cases are associated with Down syndrome,[5] and other genes can also be associated with AMKL.[6]

This category of AML is associate with 30% or more blasts in the marrow, blast are identified as being of megakaryocyte lineage by; Expression of megakaryocyte specific antigens and platelet peroxidase reaction on electron microscopy.

Diagnosis

  • In adults, the features include
    • Pancytopenia with low blast counts in the blood
    • Myelofibrosis
    • An absence of lymphadenopathy and hepatosplenomegaly
    • Poor response to chemotherapy,and short clinical course.
  • In children, the same clinical presentation but with variable course especially in very young children; both leukocytosis and organomegaly may be present in children with M7. Complete remission and long term survival are more common in children than adults.
  • In blood and bone marrow smears megakaryoblasts are usually medium sized to large cells with a high nuclear- cytoplasmic ratio. Nuclear chromatin is dense and homogeneous. There is scanty, variable basophilic cytoplasm which may be vacuolated. An irregular cytoplasmic border is often noted in some of the megakaryoblasts and occasionally projections resembling budding atypical platelets are present. Megakaryoblasts lack myeloperoxidase activity and stain negatively with sudan black B.
  • They are alpha naphthyl butyrate esterase negative and manifest variable alpha naphythyl acetate esterase activity usually in scattered clumps or granules in the cytoplasm. PAS staining also varies from negative to focal or granular positivity, to strongly positive staining.
  • A marrow aspirate is difficult to obtain in many cases because of variable degree of myelofibrosis.

References

  1. "Final Diagnosis -- Case 439". Retrieved 2008-03-08.
  2. "Acute Myeloid Leukemia - Signs and Symptoms".
  3. Hitzler JK. (2007) Acute megakaryoblastic leukemia in Down syndrome. Pediatr Blood Cancer. Dec;49(7 Suppl):1066-9. PMID: 17943965.
  4. Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A (2003). "GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome". Blood. 101 (11): 4301–4. doi:10.1182/blood-2003-01-0013. PMID 12586620.
  5. Hama A, Yagasaki H, Takahashi Y; et al. (2008). "Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome". Br. J. Haematol. 140 (5): 552–61. doi:10.1111/j.1365-2141.2007.06971.x. PMID 18275433.
  6. Gu TL, Mercher T, Tyner JW; et al. (2007). "A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia". Blood. 110 (1): 323–33. doi:10.1182/blood-2006-10-052282. PMID 17360941.
  7. Lei Q, Liu Y, Tang SQ (2007). "[Childhood acute megakaryoblastic leukemia]". Zhongguo Shi Yan Xue Ye Xue Za Zhi (in Chinese). 15 (3): 528–32. PMID 17605859.
  8. Vardiman JW, Harris NL, Brunning RD (2002). "The World Health Organization (WHO) classification of the myeloid neoplasms". Blood. 100 (7): 2292–302. doi:10.1182/blood-2002-04-1199. PMID 12239137.

External link



Template:WikiDoc Sources